The effectiveness of adeno-associated vector encoding human ATP7B cDNA variants in a mouse model of WD [34,36-38] in restoring copper metabolism has led to the evaluation of the two gene therapies, UX701 and VTX-801, for the treatment of WD in human studies (NCT04537377; NCT04884815). The gene discussed is ATP7B; the disease is Wilson disease.